According to the latest market analysis by Future Market Insights, the global Acetonitrile Market is projected to grow from USD 325.2 million in 2025 to USD 567.5 million by 2035, registering a CAGR ...
Trump's proposed generic drug tariff could reshape India's pharmaceutical strategy, US supply chains, and the global ...
Central Virginia's pharmaceutical industry received $16 million in federal funding. The funding aims to establish a domestic manufacturing pathway for essential medicines. The Virginia Advanced Pharma ...
2hon MSN
Donald Trump’s 200% tariffs on pharma: Why India’s generic medicines could still remain competitive
US President Donald Trump on Tuesday announced the final stage of his pharmaceutical tariff plan, under which imported ...
US President Donald Trump's proposed tariffs of up to 200% on imported generic medicines could put pressure on India's ...
Aurobindo Pharma said its wholly owned subsidiary, CuraTeQ Biologics, has received GMP approval from ANVISA (Agcia Nacional de Vigilcia Sanitia), Brazil's health regulator, for its biosimilars ...
The facility is already certified by the European Medicines Agency (EMA) and the World Health Organization (WHO).
The latest tariff salvo underscored Trump's goal of reshoring low-cost drug production, but displacing established suppliers ...
Aurobindo arm CuraTeQ gets Brazil regulatory nod for Hyderabad biosimilars facility: Our Bureau, Mumbai Wednesday, July 22, 2026, 14:15 Hrs [IST] CuraTeQ Biologics Private Limited ...
Aurobindo Pharma's wholly owned subsidiary CuraTeQ Biologics Private Limited has received approval from Brazil's health ...
Aurobindo's CuraTeQ Biologics facility in Hyderabad gains Anvisa approval, enhancing its presence in the Latin American ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results